The market for coenzyme Q10 (CoQ10) has achieved a compound annual growth rate (CAGR) of more than 20 percent for the past 15 years. That’s according to Scott Steinford, executive director of the CoQ10 Association, who said the growth won’t be slowing down.

April 7, 2016

The market for coenzyme Q10 (CoQ10) has achieved a compound annual growth rate (CAGR) of more than 20 percent for the past 15 years. That’s according to Scott Steinford, executive director of the CoQ10 Association, who said the growth won’t be slowing down.

There are several reasons behind CoQ10’s market success, including science to support its heart- and brain-healthy effects; improvements in technology to address bioavailability concerns; and decreasing ingredient production costs.

Looking forward, the increasing prevalence of cardiovascular disease in the United States could present opportunities for CoQ10.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like